DUBLIN – Gene therapy pioneer Ron Crystal, of Weill Cornell Medical College, is deepening his involvement in Annapurna Therapeutics SAS (formerly AAVLife SAS), the French gene therapy firm he co-founded, by licensing to the company three development programs that are already under way at Weill Cornell's Department of Genetic Medicine.